These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8385774)

  • 1. Treatment and prophylaxis of cytomegalovirus disease: a commentary.
    Yee GC
    Pharmacotherapy; 1993; 13(2):167; discussion 168. PubMed ID: 8385774
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulin.
    Krischer J; Elfenbein G; Babington R; Hong R; Jansen J; Lazarus H; Winton E; Rand K
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):89-95. PubMed ID: 1324530
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus-associated pneumonitis: pathogenesis, prevention, and treatment.
    Zaia JA; Kovacs A; Forman SJ
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):125-31. PubMed ID: 2827357
    [No Abstract]   [Full Text] [Related]  

  • 5. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
    Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results of a multicenter trial to prevent death from cytomegalovirus pneumonia with intravenous immunoglobulin after allogeneic bone marrow transplantation.
    Elfenbein G; Krischer J; Rand K; Graham-Pole J; Jansen J; Winton E; Hong R; Lazarus H; Babington R
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):138-43. PubMed ID: 2827359
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: a review of experience in one center.
    Gould FK; Freeman R; Taylor CE; Ashcroft T; Dark JH; Corris PA
    J Heart Lung Transplant; 1993; 12(4):695-9. PubMed ID: 8396437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMV immunoglobulin for prevention of pneumonitis after BMT.
    Klingemann HG; Phillips GL
    Bone Marrow Transplant; 1988 May; 3(3):235-6. PubMed ID: 2844345
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation.
    de Medeiros CR; Moreira VA; Pasquini R
    Bone Marrow Transplant; 2000 Aug; 26(4):443-4. PubMed ID: 10982292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients.
    Nguyen Q; Champlin R; Giralt S; Rolston K; Raad I; Jacobson K; Ippoliti C; Hecht D; Tarrand J; Luna M; Whimbey E
    Clin Infect Dis; 1999 Mar; 28(3):618-23. PubMed ID: 10194088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and prevention of cytomegalovirus in renal transplant patients: weighing the evidence.
    Hakkert A; Dykeman-Sharpe J
    CANNT J; 2003; 13(3):69-73; quiz 74-5. PubMed ID: 14596201
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylaxis of cytomegalovirus disease in allogeneic bone marrow transplantation.
    Grigg A; Phillips G
    J Infect Dis; 1992 May; 165(5):972-3. PubMed ID: 1314874
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand?
    Forman SJ; Zaia JA
    Blood; 1994 May; 83(9):2392-8. PubMed ID: 8167329
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytomegaloviral pneumonia in bone marrow transplantation].
    Kato S
    Nihon Rinsho; 1989 Feb; 47(2):446-51. PubMed ID: 2470936
    [No Abstract]   [Full Text] [Related]  

  • 15. Three cases of cytomegalovirus infection following pancreatic islet transplantation.
    Yakubovich N; Fung MA; Thompson DM
    Transplant Proc; 2007 Jun; 39(5):1599-603. PubMed ID: 17580197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case report of acute myelogenous leukemia treated by bone marrow transplantation from a three-year-old sister and managed in a bed isolator].
    Ito T; Ishikawa Y; Noda M; Shiraishi H
    Rinsho Ketsueki; 1986 Jan; 27(1):64-7. PubMed ID: 3012147
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients.
    Soghikian MV; Valentine VG; Berry GJ; Patel HR; Robbins RC; Theodore J
    J Heart Lung Transplant; 1996 Sep; 15(9):881-7. PubMed ID: 8889983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT). Infectious Diseases Working Party of the EBMT.
    Ljungman P; Cordonnier C; Einsele H; Bender-Götze C; Bosi A; Dekker A; De la Camara R; Gmür J; Newland AC; Prentice HG; Robinson AJ; Rovira M; Rösler W; Veil D
    Bone Marrow Transplant; 1998 Mar; 21(5):473-6. PubMed ID: 9535039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of cytomegalovirus immune globulin.
    Snydman DR
    Clin Pharm; 1992 Aug; 11(8):674-5. PubMed ID: 1324822
    [No Abstract]   [Full Text] [Related]  

  • 20. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
    Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G
    Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.